袖状胃切除术与胃旁路术安全性比较:工具变量分析
该研究基于IBM MarketScan商业保险数据库,采用工具变量分析比较袖状胃切除术与胃旁路术的安全性。在38153例减重手术患者中,袖状胃切除术2年再干预率(9.9% vs 15.6%)、并发症率(6.6% vs 9.6%)及总医疗支出($47,891 vs $55,213)均低于胃旁路术,但修正手术率略高(0.6% vs 0.4%)。
要点
- 袖状胃切除术2年再干预率和并发症率均低于胃旁路术。
- 袖状胃切除术2年总医疗支出低于胃旁路术。
- 袖状胃切除术2年修正手术率略高于胃旁路术。
核心结论
- 在商业保险患者中,袖状胃切除术术后2年内安全性优于胃旁路术,即使考虑选择偏倚。
- 袖状胃切除术修正手术风险略高,值得进一步探索。
研究设计与样本
- 工具变量分析,数据来自IBM MarketScan商业保险索赔数据库2011至2018年。
- 研究2012至2016年接受减重手术的患者,共38153例。
- 以各州前一年袖状胃切除术使用率作为工具变量,利用保险公司覆盖决策的时间差异作为自然实验。
主要发现
- 袖状胃切除术占比从2012年52.6%升至2016年75%。
- 术后2年再干预率:袖状胃切除术9.9%,胃旁路术15.6%(P < 0.001)。
- 术后2年并发症率:袖状胃切除术6.6%,胃旁路术9.6%(P = 0.001)。
- 术后2年总医疗支出:袖状胃切除术$47,891,胃旁路术$55,213(P = 0.003)。
- 术后2年修正手术率:袖状胃切除术0.6%,胃旁路术0.4%(P = 0.009)。
临床怎么用
- 在商业保险人群中,袖状胃切除术可作为减重手术的优先选择之一,因其2年内再干预、并发症及费用均较低。
- 需向患者告知袖状胃切除术修正手术风险略高于胃旁路术,并加强术后随访。
局限性
- 研究基于商业保险索赔数据,结果可能不适用于其他保险类型或人群。
- 随访时间限于术后2年,缺乏长期安全性数据。
- 使用ICD和CPT编码识别事件,可能存在编码误差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the safety of sleeve gastrectomy and gastric bypass in a large cohort of commercially insured bariatric surgery patients from the IBM MarketScan claims database, while accounting for measurable and unmeasurable sources of selection bias in who is chosen for each operation. SUMMARY OF BACKGROUND DATA: Sleeve gastrectomy has rapidly become the most common bariatric operation performed in the United States, but its longer-term safety is poorly described, and the risk of worsening gastroesophageal reflux requiring revision may be higher than previously thought. Prior studies comparing sleeve gastrectomy to gastric bypass are limited by low sample size (in randomized trials) and selection bias (in observational studies). METHODS: Instrumental variables analysis of commercially insured patients in the IBM MarketScan claims database from 2011 to 2018. We studied patients undergoing bariatric surgery from 2012 to 2016. We identified re-interventions and complications at 30 days and 2 years from surgery using Comprehensive Procedural Terminology and International Classification of Disease (ICD)-9/10 codes. To overcome unmeasured confounding, we use the prior year's sleeve gastrectomy utilization within each state as an instrumental variable-exploiting variation in the timing of payers' decisions to cover sleeve gastrectomy as a natural experiment. RESULTS: Among 38,153 patients who underwent bariatric surgery between 2012 and 2016, the share of sleeve gastrectomy rose from 52.6% (2012) to 75% (2016). At 2 years from surgery, patients undergoing sleeve gastrectomy had fewer re-interventions (sleeve 9.9%, bypass 15.6%, P < 0.001) and complications (sleeve 6.6%, bypass 9.6%, P = 0.001), and lower overall healthcare spending ($47,891 vs $55,213, P = 0.003), than patients undergoing gastric bypass. However, at the 2-year mark, revisions were slightly more common in sleeve gastrectomy than in gastric bypass (sleeve 0.6%, bypass 0.4%, P = 0.009). CONCLUSIONS AND RELEVANCE: In a large cohort of commercially insured patients, sleeve gastrectomy had a superior safety profile to gastric bypass up to 2 years from surgery, even when accounting for selection bias. However, the higher risk of revisions in sleeve gastrectomy merits further exploration.
引用
- Chhabra KR, Telem DA, Chao GF, et al. Comparative Safety of Sleeve Gastrectomy and Gastric Bypass: An Instrumental Variables Approach. Ann Surg. 2022. PMID: 33201113. doi:10.1097/SLA.0000000000004297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。